文献速递肿瘤 PET/CT

结肠局灶性18F-FDG摄取:增强CT形态学关联对结肠镜发现的价值

Incidental 18F-FDG uptake in the colon: value of contrast-enhanced CT correlation with colonoscopic findings.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2019-11-07

该回顾性研究纳入125例因增强全剂量PET/CT后行结肠镜检查的患者,评估增强CT形态学信息对结肠局灶性18F-FDG摄取定性的影响。结果显示,单独局灶性摄取诊断治疗相关病变的灵敏度54%、特异度69%、准确率65%;结合增强CT形态学改变后特异度升至90%但灵敏度降至38%,准确率80%(p=0.0001)。结论认为增强CT可提高特异度但损失灵敏度,所有结肠局灶性摄取均应行结肠镜随访。

要点

  • 单独局灶性18F-FDG摄取诊断治疗相关结肠病变的灵敏度54%、特异度69%。
  • 结合增强CT形态学改变后特异度升至90%,但灵敏度降至38%。
  • 所有结肠局灶性18F-FDG摄取均应行结肠镜随访。

核心结论

  • 分析增强CT额外形态学改变可提高结肠局灶性18F-FDG摄取对癌前及癌性病变的特异度,但导致灵敏度明显损失。
  • 因此每一处结肠局灶性摄取均应行结肠镜随访。

研究设计与样本

  • 回顾性研究纳入125例(女53例、男72例)因增强全剂量PET/CT后行结肠镜检查的患者。
  • PET/CT评估结肠局灶性示踪剂摄取并与背景比较,局灶摄取与增强CT结肠壁形态学改变关联分析。
  • 以结肠镜报告及组织病理学证实的良性、炎性、息肉样、癌前和癌性病变为参考标准。

主要发现

  • 38.4%(48/125)的患者中观察到局灶性18F-FDG摄取,共67处病变。
  • 共检出34处影响短期或长期患者管理的病变(癌前或恶性)。
  • 单独18F-FDG摄取对该合并组的灵敏度54%、特异度69%、PPV 29%、NPV 85%、准确率65%。
  • 局灶性18F-FDG摄取伴增强CT对应发现时灵敏度38%、特异度90%、PPV 50%、NPV 86%、准确率80%,诊断准确率差异有统计学意义(p=0.0001)。

关键数值与推荐

  • 单独局灶性18F-FDG摄取诊断治疗相关病变:灵敏度54%、特异度69%、PPV 29%、NPV 85%、准确率65%。
  • 局灶性18F-FDG摄取伴增强CT对应发现:灵敏度38%、特异度90%、PPV 50%、NPV 86%、准确率80%。
  • 诊断准确率差异有统计学意义(p=0.0001)。

临床怎么用

  • 结肠局灶性18F-FDG摄取应结合增强CT形态学改变进行评估以提高特异度。
  • 鉴于灵敏度损失,每一处结肠局灶性摄取均应行结肠镜随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the impact of morphological information derived from contrast-enhanced CT in the characterization of incidental focal colonic uptake in 18F-FDG PET/CT examinations. METHODS: A total of 125 patients (female: n = 53, male: n = 72) that underwent colonoscopy secondary to contrast-enhanced, full-dose PET/CT without special bowel preparation were included in this retrospective study. PET/CT examinations were assessed for focal colonic tracer uptake in comparison with the background. Focal tracer uptake was correlated with morphological changes of the colonic wall in the contrast-enhanced CT images. Colonoscopy reports were evaluated for benign, inflammatory, polypoid, precancerous, and cancerous lesions verified by histopathology, serving as a reference standard. Sensitivity, specificity, PPV, NPV, and accuracy for detection of therapeutic relevant findings were calculated for (a) sole focal tracer uptake and (b) focal tracer uptake with correlating CT findings in contrast-enhanced CT. RESULTS: In 38.4% (48/125) of the patients, a focal 18F-FDG uptake was observed within 67 lesions. Malignant lesions were endoscopically and histopathologically diagnosed in eleven patients, and nine of these were detected by focal 18F-FDG uptake. A total of 34 lesions with impact on short- or long-term patient management (either being pre- or malignant) were detected. Sensitivity, Specificity, PPV, NPV, and accuracy for sole 18F-FDG uptake for this combined group were 54%, 69%, 29%, 85%, and 65%. Corresponding results for focal 18F-FDG uptake with correlating CT findings were 38%, 90%, 50%, 86%, and 80%. This resulted in a statistically significant difference for diagnostic accuracy (p = 0.0001) CONCLUSION: By analyzing additional morphological changes in contrast-enhanced CT imaging, the specificity of focal colonic 18F-FDG uptake for precancerous and cancerous lesions can be increased but leads to a considerate loss of sensitivity. Therefore, every focal colonic uptake should be followed up by colonoscopy.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Kirchner J, Schaarschmidt BM, Kour F, et al. Incidental 18F-FDG uptake in the colon: value of contrast-enhanced CT correlation with colonoscopic findings. Eur J Nucl Med Mol Imaging. 2019. PMID: 31701188. doi:10.1007/s00259-019-04579-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。